2025-04-15 - Analysis Report
## Teladoc Health Inc (TDOC) Stock Report

**0) Executive Summary:**

Teladoc Health Inc. (TDOC) is a telehealth company providing virtual care services.  The stock has significantly underperformed the S&P 500 (VOO) over recent years, showing substantial negative returns.  While recent financial data shows relatively stable revenue, profitability and equity are concerning.  The stock's current valuation indicates a high-risk profile with potentially negative expected returns in the short term.

**1) Performance Comparison:**

Teladoc Health (TDOC) shows a cumulative return of -69.38% compared to the S&P 500 (VOO) cumulative return of 63.14%. This represents a significant divergence of -132.5 percentage points.  The relative divergence of 4.4% places it near the lower end of its historical range of divergence from the S&P 500.

**Alpha and Beta Analysis:**

The provided data shows high volatility and negative returns in recent years.  The beta, representing the stock's volatility relative to the market, fluctuates significantly, ranging from 1.3 to 8.7. The consistently negative alpha indicates underperformance against the market benchmark.  The high beta values suggest significantly higher volatility compared to the overall market.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 76.0% | 60.6% | 52.0% | -0.0 | 6.1 |
| 2016-2018  | 128.0% | 59.3% | 112.0% | -0.0 | 8.7 |
| 2017-2019  | 176.0% | 59.3% | 149.0% | 0.3 | 14.7 |
| 2018-2020  | 237.0% | 64.0% | 212.0% | 0.1 | 35.0 |
| 2019-2021  | -83.0% | 64.0% | -136.0% | 0.1 | 16.1 |
| 2020-2022  | -295.0% | 81.3% | -300.0% | 0.0 | 4.2 |
| 2021-2023  | -488.0% | 81.3% | -504.0% | -0.6 | 3.8 |
| 2022-2024  | -111.0% | 81.3% | -127.0% | -0.8 | 1.6 |
| 2023-2025  | -40.0% | 72.9% | -54.0% | -0.8 | 1.3 |


**2) Recent Price Movement:**

* **Closing Price:** $7.24
* **5-day Moving Average:** $7.35
* **20-day Moving Average:** $7.93
* **60-day Moving Average:** $9.75

The stock price is below all three moving averages, indicating a bearish trend.  The recent price change of -$0.14 represents a slight negative movement.

**3) Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.4585 (High Risk)
* **RSI:** 26.03 (Oversold)
* **PPO:** -0.04 (Bearish)
* **20-Day Relative Divergence Change:** -1.7 (Short-term bearish)
* **Expected Return:** -1772.2% (Extremely Negative)


The technical indicators paint a bearish picture. The over sold RSI might suggest a potential bounce, but the negative PPO and significant negative expected return suggest considerable caution is warranted.  The extremely negative expected return (-1772.2%) suggests a high level of risk and a significantly negative outlook, especially when compared to the S&P 500.

**4) Recent Earnings Analysis:**

The provided earnings data shows consistent negative EPS, indicating ongoing losses.  Revenue has remained relatively stable, but without profitability, this is insufficient to indicate a healthy financial picture.


| Date       | EPS    | Revenue       |
|------------|--------|---------------|
| 2024-10-31 | -0.19  | $0.64 B       |
| 2024-08-01 | -4.92  | $0.64 B       |
| 2024-04-26 | -0.49  | $0.65 B       |
| 2023-10-27 | -0.35  | $0.66 B       |
| 2024-10-31 | -0.35  | $0.66 B       |


**5) Financial Information:**

The financial information reveals concerning trends. While revenue remains relatively consistent, profitability is low and ROE is consistently negative, indicating the company is not generating sufficient returns on its equity.


**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $0.64B | 70.50% |
| 2024-09-30 | $0.64B | 71.94% |
| 2024-06-30 | $0.64B | 70.73% |
| 2024-03-31 | $0.65B | 69.89% |
| 2023-12-31 | $0.66B | 70.72% |

**Capital and Profitability:**

| Quarter | Equity | ROE      |
|---------|---------|----------|
| 2024-12-31 | $1.49B | -3.25%   |
| 2024-09-30 | $1.51B | -2.21%   |
| 2024-06-30 | $1.50B | -55.77%  |
| 2024-03-31 | $2.29B | -3.58%   |
| 2023-12-31 | $2.33B | -1.24%   |


**6) Overall Analysis:**

TDOC's performance has been significantly poor compared to the S&P 500, exhibiting considerable negative returns and high volatility.  While revenue remains relatively stable, the company is consistently unprofitable and shows negative ROE.  Technical indicators suggest a bearish trend. The extremely negative expected return and high risk profile makes long-term investment questionable, unless there's a significant change in the company's fundamentals and financial performance.  Further investigation into the reasons for the negative performance and the company's long-term strategy is crucial before considering any investment.  The risk associated with this stock is very high.
